Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 2
2007 1
2008 4
2009 2
2010 2
2011 6
2012 6
2013 11
2014 3
2015 2
2016 2
2017 4
2018 7
2019 3
2020 3
2021 12
2022 11
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer.
Li S, Yu W, Xie F, Luo H, Liu Z, Lv W, Shi D, Yu D, Gao P, Chen C, Wei M, Zhou W, Wang J, Zhao Z, Dai X, Xu Q, Zhang X, Huang M, Huang K, Wang J, Li J, Sheng L, Liu L. Li S, et al. Among authors: luo h. Nat Commun. 2023 Jan 3;14(1):8. doi: 10.1038/s41467-022-35431-x. Nat Commun. 2023. PMID: 36596787 Free PMC article. Clinical Trial.
Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody.
Song X, Xiong A, Wu F, Li X, Wang J, Jiang T, Chen P, Zhang X, Zhao Z, Liu H, Cheng L, Zhao C, Wang Z, Pan C, Cui X, Xu T, Luo H, Zhou C. Song X, et al. Among authors: luo h. J Immunother Cancer. 2023 Feb;11(2):e006234. doi: 10.1136/jitc-2022-006234. J Immunother Cancer. 2023. PMID: 36854570 Free PMC article. Clinical Trial.
Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial.
Zhang G, Yuan J, Pan C, Xu Q, Cui X, Zhang J, Liu M, Song Z, Wu L, Wu D, Luo H, Hu Y, Jiao S, Yang B. Zhang G, et al. Among authors: luo h. EBioMedicine. 2023 Apr;90:104515. doi: 10.1016/j.ebiom.2023.104515. Epub 2023 Mar 13. EBioMedicine. 2023. PMID: 36921563 Free PMC article. Clinical Trial.
Using the NONCODE Database Resource.
Xiyuan L, Dechao B, Liang S, Yang W, Shuangsang F, Hui L, Haitao L, Chunlong L, Wenzheng F, Runsheng C, Yi Z. Xiyuan L, et al. Among authors: haitao l. Curr Protoc Bioinformatics. 2017 Jun 27;58:12.16.1-12.16.19. doi: 10.1002/cpbi.25. Curr Protoc Bioinformatics. 2017. PMID: 28654727
Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Zhang S, Li N, Wang F, Liu H, Zhang Y, Xiao J, Qiu W, Zhang C, Fan X, Qiu M, Li M, Tang H, Fan S, Wang J, Luo H, Li X, Lin J, Huang Y, Liang L. Zhang S, et al. Among authors: luo h. Pharmacol Res. 2023 Nov;197:106974. doi: 10.1016/j.phrs.2023.106974. Epub 2023 Oct 28. Pharmacol Res. 2023. PMID: 37898442 Free article.
93 results